Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRSP
Stock Latest News
The Fly
Crispr Therapeutics price target lowered to $90 from $93 at BofA
5d ago
CRSP
Premium
Market News
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
7d ago
TEM
ARKF
Premium
Market News
Cathie Wood’s ARK Adds to CRISPR Stock — Here’s What Else It Traded This Week
13d ago
WRD
ACHR
Premium
Market News
Cathie Wood Adds to WeRide (WRD) and CRISPR, Trims Ibotta (IBTA) in Holiday Trades
16d ago
WRD
CRSP
Premium
Market News
Cathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
17d ago
WRD
CRSP
Premium
Ratings
Early but Compelling CTX112 Data Underpin Buy Rating and $80 Target for CRISPR Therapeutics
19d ago
CRSP
Premium
Ratings
Buy Rating on CRISPR Therapeutics Driven by Promising zugo‑cel Data, Expanding Gene-Editing Pipeline, and Favorable Long-Term Risk–Reward Profile
19d ago
CRSP
Premium
Ratings
CRISPR Therapeutics: Early Autoimmune Promise, Best-in-Class Oncology Data, and Eli Lilly Partnership Support Buy Rating
19d ago
CRSP
Premium
The Fly
Crispr Therapeutics provides updates on zugo-cel
20d ago
CRSP
Premium
Ratings
Buy Rating for Crispr Therapeutics AG: Pediatric Market Potential and Long-term Growth Opportunities
1M ago
CRSP
Premium
Weekend Updates
Crispr Therapeutics AG: Stock Surge Amid Challenges
1M ago
CRSP
Premium
Market News
ARKB, HOOD, SHOP, WRD: Cathie Wood Expands Crypto and AI Bets, Trims Stakes in Roku and GitLab (GTLB) Stocks
1M ago
KDK
SYM
Premium
The Fly
Crispr Therapeutics rumor highlighted in Betaville blog
1M ago
CRSP
Premium
The Fly
Crispr Therapeutics price target lowered to $74 from $82 at Chardan
2M ago
CRSP
Premium
Market News
Cathie Wood Doubles Down on This AI Stock, Cuts GitLab (GTLB) Again
2M ago
BLSH
CRCL
Premium
Weekend Updates
Crispr Therapeutics AG Faces Stock Price Slide
2M ago
CRSP
Premium
Market News
Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS
2M ago
AMD
ACHR
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
2M ago
BNTC
CRSP
Premium
The Fly
Crispr Therapeutics rumor highlighted in Betaville blog
2M ago
CRSP
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
2M ago
CRSP
Premium
Market News
Cathie Wood Sells Tesla (TSLA) and SoFi Stocks, Makes a $34M Bet on This USDC Giant
2M ago
TEM
CRCL
Premium
The Fly
Crispr Therapeutics price target lowered to $77 from $87 at Citi
2M ago
CRSP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
